A detailed history of Mcf Advisors LLC transactions in Vericel Corp stock. As of the latest transaction made, Mcf Advisors LLC holds 593 shares of VCEL stock, worth $33,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares
593
Previous 455 30.33%
Holding current value
$33,984
Previous $20,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.25 - $53.56 $5,830 - $7,391
138 Added 30.33%
593 $25,000
Q2 2024

Aug 05, 2024

SELL
$41.71 - $52.9 $1,126 - $1,428
-27 Reduced 5.6%
455 $20,000
Q1 2024

Apr 16, 2024

BUY
$32.52 - $52.33 $7,251 - $11,669
223 Added 86.1%
482 $25,000
Q4 2023

Feb 01, 2024

BUY
$30.85 - $37.09 $3,640 - $4,376
118 Added 83.69%
259 $9,000
Q3 2023

Oct 19, 2023

BUY
$31.69 - $39.25 $4,468 - $5,534
141 New
141 $4,000
Q3 2022

Nov 09, 2022

BUY
$22.62 - $32.54 $9,794 - $14,089
433 New
433 $10,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.